
IQVIA Holdings Faces Financial Strain Amid Declining Metrics and Increased Costs
2025-11-04 16:59:13IQVIA Holdings, Inc. has recently experienced a change in its evaluation, reflecting a shift in financial metrics following a challenging quarter in June 2025. Key indicators show a decline in the interest coverage ratio and an increase in raw material costs, alongside rising leverage concerns and underperformance relative to the S&P 500.
Read MoreIs IQVIA Holdings, Inc. overvalued or undervalued?
2025-10-21 12:10:45As of 17 October 2025, the valuation grade for IQVIA Holdings, Inc. moved from very expensive to expensive. Based on the current metrics, the company appears to be overvalued. The P/E ratio stands at 29, which is significantly higher than the peer average of 29.20 for Laboratory Corp. of America Holdings and 27.82 for Quest Diagnostics, Inc. Additionally, the EV to EBITDA ratio of 15.15 is also above the peer average of 14.94 for Laboratory Corp. of America, indicating a premium valuation compared to its peers. In terms of returns, IQVIA has underperformed against the S&P 500 over the one-year and three-year periods, with returns of -12.54% and 12.90%, respectively, compared to the S&P 500's 14.08% and 81.19%. This underperformance further supports the conclusion that IQVIA Holdings, Inc. is currently overvalued in the market....
Read More
IQVIA Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics
2025-10-20 16:20:24IQVIA Holdings, Inc. has adjusted its valuation, showcasing a P/E ratio of 29 and a price-to-book value of 6.50. The company has demonstrated resilience with a recent 1-week return of 3.22%, although its long-term performance has lagged behind the S&P 500.
Read MoreIs IQVIA Holdings, Inc. overvalued or undervalued?
2025-10-20 12:28:02As of 17 October 2025, the valuation grade for IQVIA Holdings, Inc. has moved from very expensive to expensive, indicating a shift towards a less favorable assessment. The company appears overvalued based on its current metrics, with a P/E ratio of 29, a Price to Book Value of 6.50, and an EV to EBITDA of 15.15. In comparison, Laboratory Corp. of America Holdings has a fair P/E of 29.20, while Quest Diagnostics, Inc. shows a fair P/E of 27.82, suggesting that IQVIA is trading at a premium relative to its peers. In terms of recent performance, IQVIA has outperformed the S&P 500 over the past week and month, with returns of 3.22% and 9.57%, respectively. However, its year-to-date return of 4.09% and one-year return of -12.54% indicate a struggle to keep pace with the broader market, which reinforces the notion that the stock may be overvalued at its current price of 204.55....
Read MoreIs IQVIA Holdings, Inc. overvalued or undervalued?
2025-10-19 12:05:26As of 17 October 2025, the valuation grade for IQVIA Holdings, Inc. moved from very expensive to expensive. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 29, an EV to EBITDA of 15.15, and a Price to Book Value of 6.50. In comparison, Laboratory Corp. of America Holdings has a P/E ratio of 29.20, while Quest Diagnostics, Inc. stands at 27.82, indicating that IQVIA is trading at a premium relative to its peers. Despite a strong short-term performance, with a 1-week return of 3.22% compared to the S&P 500's 1.70%, the longer-term returns are concerning, particularly the 1-year return of -12.54% versus the S&P 500's 14.08%. This suggests that while IQVIA may have performed well recently, its overall valuation does not justify its current price level....
Read More
IQVIA Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics
2025-10-07 19:52:53IQVIA Holdings, Inc. has recently revised its evaluation amid market fluctuations, with its stock priced at $205.02. The company has experienced significant volatility over the past year, with a high of $237.34 and a low of $134.65, reflecting mixed technical indicators and performance compared to the S&P 500.
Read MoreIs IQVIA Holdings, Inc. technically bullish or bearish?
2025-10-07 12:22:43As of 3 October 2025, the technical trend for IQVIA Holdings, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages are also bullish, supporting the overall positive stance. However, the weekly RSI is bearish, indicating some short-term weakness. The Bollinger Bands show a mildly bullish trend on the weekly and bullish on the monthly. The KST is bullish weekly but bearish monthly, and Dow Theory indicates no trend weekly and mildly bullish monthly. In terms of performance, IQVIA has outperformed the S&P 500 over the past week and month, with returns of 13.45% and 9.24% compared to 1.09% and 4.15% for the index, respectively. However, it has underperformed over the longer term, with a 1-year return of -10.80% versus 17.82% for the S&P 500. Overall, the current stance is bullish, driven by strong moving averages and M...
Read MoreIs IQVIA Holdings, Inc. technically bullish or bearish?
2025-10-06 12:12:43As of 3 October 2025, the technical trend for IQVIA Holdings, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supporting the overall bullish stance, while the daily moving averages also indicate bullish momentum. However, the weekly RSI is bearish, which suggests some caution. The Bollinger Bands are bullish on both weekly and monthly time frames, reinforcing the positive outlook. Despite this bullish sentiment, the company has underperformed against the S&P 500 over the 1Y and 3Y periods, returning -9.13% and 10.97% respectively, compared to the S&P 500's 17.82% and 82.57%. Overall, the current technical stance is bullish, but with mixed signals that indicate potential volatility....
Read MoreIs IQVIA Holdings, Inc. technically bullish or bearish?
2025-10-05 11:57:54As of 3 October 2025, the technical trend for IQVIA Holdings, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and Bollinger Bands are also indicating a bullish stance. However, the weekly RSI is bearish, and the KST shows a bullish signal on the weekly but bearish on the monthly. Moving averages are bullish on the daily timeframe. Dow Theory indicates a mildly bullish trend on both weekly and monthly timeframes. In terms of performance, IQVIA has outperformed the S&P 500 over the past week and month, with returns of 15.08% and 11.92% compared to 1.09% and 4.15% for the index, respectively. However, the longer-term returns show underperformance, with a 1-year return of -9.13% versus the S&P 500's 17.82%. Overall, the current technical stance is bullish, driven primarily by the weekly MACD and Bollinger Bands....
Read More





